Cargando…
RF11 | PSAT272 Suppressive Tumor Immune Microenvironment is Associated with Aggressive Differentiated Thyroid Cancer
BACKGROUND: The incidence of differentiated thyroid cancer (DTC) has tripled over the last 30 years in the US. While most patients respond to conventional treatment, some have an aggressive course with a dismal 5-year survival of 15.3%. There is a need to identify novel markers in addition to clinic...
Autores principales: | Kotwal, Anupam, Hajric, Kemal, Vance, Krysten, Duarte, Ernesto M, Yuil-Valdes, Ana, Hollingsworth, Michael, Ganti, Apar, Band, Hamid, Swanson, Benjamin, Bennett, Robert, Goldner, Whitney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628110/ http://dx.doi.org/10.1210/jendso/bvac150.1764 |
Ejemplares similares
-
SAT524 Relaxin: A Novel Marker for Pro-Tumoral Thyroid Cancer Microenvironment?
por: Kotwal, Anupam, et al.
Publicado: (2023) -
MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020) -
RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022) -
RF35 | PSAT257 The Severity of Subacute Thyroiditis Depends on Its Causative Agent
por: Brancatella, Alessandro, et al.
Publicado: (2022) -
RF23 | PSAT240 Suboptimal Thyroid Hormone Replacement is Associated with Worse Hospital Outcomes
por: Bianco, Antonio C, et al.
Publicado: (2022)